567 related articles for article (PubMed ID: 7906096)
1. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
2. Canine epitheliotropic cutaneous T-cell lymphoma: an investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality.
Moore PF; Affolter VK; Graham PS; Hirt B
Vet Dermatol; 2009 Oct; 20(5-6):569-76. PubMed ID: 20178496
[TBL] [Abstract][Full Text] [Related]
3. [Clinical, morphologic and immunophenotypic data based on 10 cases of canine muco-cutaneous epidermotropic T-lymphoma (analogous to Mycosis Funcgoïde). Important of an animal model of spontaneous pathology].
Magnol JP; Ghernati I; Marchal T; Chabanne L; Delverdier A; Fournel C
Bull Acad Natl Med; 1996 Feb; 180(2):449-62. PubMed ID: 8705383
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
5. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
7. Canine cutaneous epitheliotropic T-cell lymphoma with vesiculobullous lesions resembling human bullous mycosis fungoides.
Bizikova P; Linder KE; Suter SE; Van Wettere AJ; Olivry T
Vet Dermatol; 2009 Aug; 20(4):281-8. PubMed ID: 19659540
[TBL] [Abstract][Full Text] [Related]
8. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
Horst BA; Kasper R; LeBoit PE
Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
[TBL] [Abstract][Full Text] [Related]
9. Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules.
Moore PF; Schrenzel MD; Affolter VK; Olivry T; Naydan D
Am J Pathol; 1996 May; 148(5):1699-708. PubMed ID: 8623937
[TBL] [Abstract][Full Text] [Related]
10. Canine cutaneous epitheliotropic T-cell lymphoma: a review.
Fontaine J; Bovens C; Bettenay S; Mueller RS
Vet Comp Oncol; 2009 Mar; 7(1):1-14. PubMed ID: 19222826
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
13. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
Wood GS; Dubiel C; Mueller C; Abel EA; Hoppe RT; Edinger A; Weissman I; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
[TBL] [Abstract][Full Text] [Related]
14. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
Knapp CF; Mathew R; Messina JL; Lien MH
Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
[TBL] [Abstract][Full Text] [Related]
16. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
17. Expression of monoclonal antibody HML-1-defined alpha E beta 7 integrin in cutaneous T cell lymphoma.
Simonitsch I; Volc-Platzer B; Mosberger I; Radaszkiewicz T
Am J Pathol; 1994 Nov; 145(5):1148-58. PubMed ID: 7977645
[TBL] [Abstract][Full Text] [Related]
18. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
[TBL] [Abstract][Full Text] [Related]
19. Mycosis fungoides with a CD56+ immunophenotype.
Wain EM; Orchard GE; Mayou S; Atherton DJ; Misch KJ; Russell-Jones R
J Am Acad Dermatol; 2005 Jul; 53(1):158-63. PubMed ID: 15965442
[TBL] [Abstract][Full Text] [Related]
20. Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases.
Fontaine J; Heimann M; Day MJ
Vet Dermatol; 2010 Jun; 21(3):267-75. PubMed ID: 20141606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
